311 related articles for article (PubMed ID: 24967908)
41. Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis.
Khatonier R; Ahmed G; Sarmah P; Narain K; Khan AM
Immunobiology; 2021 Nov; 226(6):152148. PubMed ID: 34773853
[TBL] [Abstract][Full Text] [Related]
42. Wnt5a Signaling Promotes Host Defense against
Chakraborty A; Kurati SP; Mahata SK; Sundar S; Roy S; Sen M
J Immunol; 2017 Aug; 199(3):992-1002. PubMed ID: 28659356
[No Abstract] [Full Text] [Related]
43. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
Reiner NE
J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
[TBL] [Abstract][Full Text] [Related]
44. Characterization of microRNA expression profiles in Leishmania-infected human phagocytes.
Geraci NS; Tan JC; McDowell MA
Parasite Immunol; 2015 Jan; 37(1):43-51. PubMed ID: 25376316
[TBL] [Abstract][Full Text] [Related]
45. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
Vendrame CM; Carvalho MD; Rios FJ; Manuli ER; Petitto-Assis F; Goto H
Scand J Immunol; 2007; 66(2-3):287-96. PubMed ID: 17635806
[TBL] [Abstract][Full Text] [Related]
46. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
47. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
48. Neutrophil elastase promotes
Dias BT; Dias-Teixeira KL; Godinho JP; Faria MS; Calegari-Silva T; Mukhtar MM; Lopes U; Mottram JC; Lima APCA
FASEB J; 2019 Oct; 33(10):10794-10807. PubMed ID: 31284755
[TBL] [Abstract][Full Text] [Related]
49. Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1.
Gupta P; Srivastav S; Saha S; Das PK; Ukil A
Cell Death Differ; 2016 Nov; 23(11):1815-1826. PubMed ID: 27662364
[TBL] [Abstract][Full Text] [Related]
50. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
51.
Verma S; Mandal A; Ansari MY; Kumar A; Abhishek K; Ghosh AK; Kumar A; Kumar V; Das S; Das P
Front Immunol; 2018; 9():63. PubMed ID: 29434593
[No Abstract] [Full Text] [Related]
52. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.
Melby PC; Tryon VV; Chandrasekar B; Freeman GL
Infect Immun; 1998 May; 66(5):2135-42. PubMed ID: 9573100
[TBL] [Abstract][Full Text] [Related]
53. mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection.
Cheekatla SS; Aggarwal A; Naik S
Med Microbiol Immunol; 2012 Feb; 201(1):37-46. PubMed ID: 21567173
[TBL] [Abstract][Full Text] [Related]
54. Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.
Baharia RK; Tandon R; Sahasrabuddhe AA; Sundar S; Dube A
PLoS One; 2014; 9(6):e97911. PubMed ID: 24926878
[TBL] [Abstract][Full Text] [Related]
55. Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters.
Kumari S; Misra P; Tandon R; Samant M; Sundar S; Dube A
PLoS One; 2012; 7(1):e30746. PubMed ID: 22292030
[TBL] [Abstract][Full Text] [Related]
56. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
[TBL] [Abstract][Full Text] [Related]
57. Super enhancer-mediated transcription of miR146a-5p drives M2 polarization during Leishmania donovani infection.
Das S; Mukherjee S; Ali N
PLoS Pathog; 2021 Feb; 17(2):e1009343. PubMed ID: 33630975
[TBL] [Abstract][Full Text] [Related]
58. Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.
Adhikari A; Gupta G; Majumder S; Banerjee S; Bhattacharjee S; Bhattacharya P; Kumari S; Haldar S; Majumdar SB; Saha B; Majumdar S
PLoS One; 2012; 7(7):e40265. PubMed ID: 22792256
[TBL] [Abstract][Full Text] [Related]
59. Inbred mouse strains differentially susceptible to Leishmania donovani infection differ in their immune cell metabolism.
Bodhale NP; Pal S; Kumar S; Chattopadhyay D; Saha B; Chattopadhyay N; Bhattacharyya M
Cytokine; 2018 Dec; 112():12-15. PubMed ID: 29885992
[TBL] [Abstract][Full Text] [Related]
60. Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation.
Bertholet S; Dickensheets HL; Sheikh F; Gam AA; Donnelly RP; Kenney RT
Infect Immun; 2003 Apr; 71(4):2095-101. PubMed ID: 12654831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
